Suppr超能文献

评估轴性脊柱关节炎中的肌肉减少症、肌肉减少症前期和营养不良:来自西班牙队列的见解。

Assessing Sarcopenia, Presarcopenia, and Malnutrition in Axial Spondyloarthritis: Insights from a Spanish Cohort.

作者信息

Berbel-Arcobé Laura, Benavent Diego, Valencia-Muntalà Lidia, Gómez-Vaquero Carmen, Juanola Xavier, Nolla Joan M

机构信息

Rheumatology Department, Hospital Universitari de Bellvitge-IDIBELL, Carrer de la Feixa Llarga S/N, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.

出版信息

Nutrients. 2025 Mar 14;17(6):1019. doi: 10.3390/nu17061019.

Abstract

BACKGROUND/OBJECTIVES: Sarcopenia, defined by a loss of muscle mass, strength, and function, is a potential comorbidity in axial spondyloarthritis (axSpA). Its prevalence, along with malnutrition, remains unclear.

METHODS

This cross-sectional study assessed sarcopenia (using the European Working Group on Sarcopenia in Older People (EWGSOP-2) criteria), presarcopenia, and malnutrition (using the Global Leadership Initiative on Malnutrition (GLIM) criteria) in a Spanish axSpA cohort. We included 94 patients aged ≥ 50 years. Sarcopenia was evaluated using the SARC-F questionnaire and by measuring muscle strength, mass, and performance. Presarcopenia was defined as low muscle mass alone. Malnutrition was assessed using body mass index (BMI) and fat-free mass index (FFMI).

RESULTS

The prevalence of sarcopenia, presarcopenia, and malnutrition was 3.2%, 23.4%, and 10.6%, respectively. Sarcopenia correlated with worse functionality and quality of life (Bath Ankylosing Spondylitis Functional Index (BASFI) 7.6 ± 1.2 vs. 3.6 ± 2.5, = 0.02; ASAS Health Index (ASAS-HI) 11 ± 2 vs. 5.6 ± 3.7, = 0.03). Presarcopenia was linked to a lower BMI (24.7 ± 4.1 vs. 29.1 ± 4.2, < 0.01), FFMI (16.1 ± 2 vs. 19.6 ± 2.6, < 0.01), and reduced biologic treatment use (31.8% vs. 61.1%, = 0.03). Malnourished patients had lower muscle mass (5.14 ± 0.73 vs. 6.23 ± 0.96, < 0.01). SARC-F showed 100% sensitivity and 75.8% specificity for sarcopenia detection.

CONCLUSIONS

Despite low sarcopenia prevalence, presarcopenia and malnutrition are frequent, highlighting the need for early detection in axSpA.

摘要

背景/目的:肌肉减少症定义为肌肉质量、力量和功能的丧失,是轴性脊柱关节炎(axSpA)的一种潜在合并症。其患病率以及与营养不良的关系仍不明确。

方法

这项横断面研究采用欧洲老年人肌肉减少症工作组(EWGSOP - 2)标准评估西班牙axSpA队列中的肌肉减少症、疑似肌肉减少症和营养不良(采用全球营养不良领导倡议(GLIM)标准)。我们纳入了94名年龄≥50岁的患者。使用SARC - F问卷并通过测量肌肉力量、质量和功能来评估肌肉减少症。疑似肌肉减少症定义为仅肌肉质量低。使用体重指数(BMI)和去脂体重指数(FFMI)评估营养不良。

结果

肌肉减少症、疑似肌肉减少症和营养不良的患病率分别为3.2%、23.4%和10.6%。肌肉减少症与功能和生活质量较差相关(强直性脊柱炎功能指数(BASFI)7.6±1.2对3.6±2.5,P = 0.02;ASAS健康指数(ASAS - HI)11±2对5.6±3.7,P = 0.03)。疑似肌肉减少症与较低的BMI(24.7±4.1对29.1±4.2,P<0.01)、FFMI(16.1±2对19.6±2.6,P<0.01)以及生物治疗使用率降低相关(31.8%对61.1%,P = 0.03)。营养不良患者的肌肉质量较低(5.14±0.73对6.23±0.96,P<0.01)。SARC - F对肌肉减少症检测的敏感性为100%,特异性为75.8%。

结论

尽管肌肉减少症患病率较低,但疑似肌肉减少症和营养不良很常见,突出了axSpA早期检测的必要性。

相似文献

2
Comparative evaluation of screening tools for sarcopenia in patients with axial spondyloarthritis.
Sci Rep. 2024 Jun 22;14(1):14407. doi: 10.1038/s41598-024-65120-2.
3
Prevalence of sarcopenia in patients older than 75 years admitted for hip fracture.
Endocrinol Diabetes Nutr (Engl Ed). 2023 Jun-Jul;70(6):396-407. doi: 10.1016/j.endien.2023.06.001. Epub 2023 Jun 8.
5
Age, body mass index, and function as the independent predictors of sarcopenia in axial spondyloarthritis: a cross-sectional analysis.
Clin Rheumatol. 2023 Dec;42(12):3257-3265. doi: 10.1007/s10067-023-06770-x. Epub 2023 Sep 27.
7
Impact of malnutrition and sarcopenia on quality of life in patients with inflammatory bowel disease: A multicentre study.
J Cachexia Sarcopenia Muscle. 2023 Dec;14(6):2663-2675. doi: 10.1002/jcsm.13341. Epub 2023 Oct 1.

引用本文的文献

1
Association of Low Free T3 with Disease Presence and Activity in Ankylosing Spondylitis.
Int J Mol Sci. 2025 Aug 14;26(16):7862. doi: 10.3390/ijms26167862.

本文引用的文献

1
Navigating the Intersection: Sarcopenia and Sarcopenic Obesity in Inflammatory Bowel Disease.
Biomedicines. 2024 May 30;12(6):1218. doi: 10.3390/biomedicines12061218.
2
Evaluating sarcopenia prevalence and SARC-F effectiveness in elderly Spanish women with RA: a comparative study of EWGSOP criteria.
Front Med (Lausanne). 2024 May 10;11:1392604. doi: 10.3389/fmed.2024.1392604. eCollection 2024.
3
Frequency of sarcopenia in Turkish women with systemic lupus erythematosus.
Lupus Sci Med. 2024 May 8;11(1):e001204. doi: 10.1136/lupus-2024-001204.
4
Is sarcopenia a real concern in ankylosing spondylitis? A systematic literature review.
Eur Geriatr Med. 2024 Aug;15(4):903-912. doi: 10.1007/s41999-024-00968-1. Epub 2024 Apr 3.
5
The prevalence of sarcopenia in spondyloarthritis patients: a meta-analysis.
Arthritis Res Ther. 2024 Mar 16;26(1):72. doi: 10.1186/s13075-024-03299-5.
6
Anemia and Low Body Mass Index in Axial Spondyloarthritis: Results from ChinaSpA, the Chinese Spondyloarthritis Registry.
Rheumatol Ther. 2024 Apr;11(2):397-409. doi: 10.1007/s40744-024-00646-5. Epub 2024 Feb 13.
7
Age, body mass index, and function as the independent predictors of sarcopenia in axial spondyloarthritis: a cross-sectional analysis.
Clin Rheumatol. 2023 Dec;42(12):3257-3265. doi: 10.1007/s10067-023-06770-x. Epub 2023 Sep 27.
9
The bone marrow side of axial spondyloarthritis.
Nat Rev Rheumatol. 2023 Aug;19(8):519-532. doi: 10.1038/s41584-023-00986-6. Epub 2023 Jul 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验